Literature DB >> 30375839

Tic-related obsessive–compulsive disorder

Tamara Pringsheim1, John Piacentini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30375839      PMCID： PMC6203551          DOI： 10.1503/jpn.180086

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  11 in total

1.  Tic-Related Versus Tic-Free Obsessive-Compulsive Disorder: Clinical Picture and 2-Year Natural Course.

Authors:  Froukje E de Vries; Danielle C Cath; Adriaan W Hoogendoorn; Patricia van Oppen; Gerrit Glas; Dick J Veltman; Odile A van den Heuvel; Anton J L M van Balkom
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

2.  A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.

Authors:  Joseph F McGuire; John Piacentini; Adam B Lewin; Erin A Brennan; Tanya K Murphy; Eric A Storch
Journal:  Depress Anxiety       Date:  2015-06-30       Impact factor: 6.505

3.  Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.

Authors:  John S March; Martin E Franklin; Henrietta Leonard; Abbe Garcia; Phoebe Moore; Jennifer Freeman; Edna Foa
Journal:  Biol Psychiatry       Date:  2007-02-01       Impact factor: 13.382

4.  Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

Authors: 
Journal:  JAMA       Date:  2004-10-27       Impact factor: 56.272

Review 5.  Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment.

Authors:  Matthew E Hirschtritt; Michael H Bloch; Carol A Mathews
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

Review 6.  A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Authors:  M H Bloch; A Landeros-Weisenberger; B Kelmendi; V Coric; M B Bracken; J F Leckman
Journal:  Mol Psychiatry       Date:  2006-04-04       Impact factor: 15.992

Review 7.  The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis.

Authors:  Tord Ivarsson; Gudmundur Skarphedinsson; Hege Kornør; Brynhildur Axelsdottir; Sølvi Biedilæ; Isobel Heyman; Fernando Asbahr; Per Hove Thomsen; Naomi Fineberg; John March
Journal:  Psychiatry Res       Date:  2015-01-28       Impact factor: 3.222

Review 8.  Remote cognitive-behavior therapy for obsessive-compulsive symptoms: A meta-analysis.

Authors:  Bethany M Wootton
Journal:  Clin Psychol Rev       Date:  2015-10-20

9.  Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study.

Authors:  Gabriele Masi; Chiara Pfanner; Paola Brovedani
Journal:  J Psychiatr Res       Date:  2013-05-08       Impact factor: 4.791

Review 10.  Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.

Authors:  David Veale; Sarah Miles; Nicola Smallcombe; Haben Ghezai; Ben Goldacre; John Hodsoll
Journal:  BMC Psychiatry       Date:  2014-11-29       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.